INVO Bioscience, Inc. filed its 10-K on Apr 17, 2023 for the period ending Dec 31, 2022. In this report its auditor, M & K CPAS, PLLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | -1.32% | -10.24% | -44.44% |
05-15 | INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Top Premarket Decliners | MT |
1st Jan change | Capi. | |
---|---|---|
-44.44% | 2.86M | |
-3.87% | 184B | |
-0.52% | 107B | |
-3.65% | 67.9B | |
-5.79% | 46.49B | |
+13.26% | 45.81B | |
+6.38% | 42.55B | |
+18.83% | 30.78B | |
+16.53% | 26.11B | |
-6.80% | 23.9B |
- Stock Market
- Equities
- INVO Stock
- News INVO Bioscience, Inc.
- INVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt